Other News To Note
Monday, August 29, 2011
NeuroHealing Pharmaceuticals Inc., of Newton, Mass., received a grant from the Michael J. Fox Foundation for Parkinson's Research to advance the clinical development of NH004, specifically a multicenter, double-blind, placebo-controlled crossover study testing the drug in Parkinson's patients suffering from sialorrhea.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.